The novel coronavirus pandemic has had a substantial impact on mental health, as well as on its treatment. In the second part of a two-part webinar series on psychiatry perspectives in a post-pandemic world, Richard Weisler, MD, and Allan Chrisman, MD, build upon the dialogue of the pandemic’s impact on health care providers and first responders discussed in “Psychiatry Perspectives On COVID-19: Impact On Health Care Providers & First Responders And A Path Forward (Series 1 of 2)” and shift the focus to discuss the ways in which COVID-19 has affected individuals’ mental health and well-being. They also discuss new innovations and technological approaches to psychiatric patient care and identify effective treatment methods. Moderated by Phillip Lai, PharmD, BCPP, this webinar closes with Drs. Chrisman and Weisler charting a path forward out of the more lingering effects of COVID-19.
Allan Chrisman, MD
Associate Professor Emeritus, Duke University School of Medicine
Richard Weisler, MD
Psychiatrist, Richard H. Weisler, MD & Associates; Adjunct Professor of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Adjunct Associate Professor of Psychiatry & Behavioral Sciences, Duke University Medical Center
Phillip Lai, PharmD, BCPP
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
Allan Chrisman, MD, is an Associate Professor Emeritus at Duke University School of Medicine. During his 40 years of practice in general, adult, and child psychiatry, he worked on inpatient, residential, and outpatient settings. He practiced for nearly 14 years at Harvard Community Health Plan (a health maintenance organization [HMO]), where he was a consultant to pediatric and internal medicine practices. Since retiring, he has pursued his interest in disaster mental health as an American Red Cross Disaster Health Services & Disaster Mental Health Volunteer. Dr. Chrisman received his medical degree from the George Washington University School of Medicine.
Richard Weisler, MD, has had a psychiatric practice since 1980 where he and his team follow more than 2,000 patients with a mixture of psychiatric disorders. He is an Adjunct Professor of Psychiatry at the University of North Carolina Chapel Hill School of Medicine, where he has served for many years as Chairman of the Board of Visitors for the Department of Psychiatry. Dr. Weisler also serves as an Adjunct Associate Professor of Psychiatry & Behavioral Sciences at Duke University Medical Center. He received his medical degree from the University of North Carolina at Chapel Hill and is board certified by the American Board of Psychiatry & Neurology.
Phillip Lai, PharmD, BCPP, is a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc.